DMC: Domesco Medical Import - Export Joint-Stock Corporation - Summary | Jitta

Domesco Medical Import - Export Joint-Stock Corporation

VNM:DMC

Price
₫58,000.00
Loss Chance
49.2%
4.51JITTA SCORE
71.29%Over Jitta Line
Jitta Ranking
248 / 622
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (36)
Recent Business Performance (37)
Financial Strength (71)
Return to Shareholders (39)
Competitive Advantage (69)
Jitta Signs
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
CapExVery Low
SG&A to SalesDecreasing Every Year
Revenue and EarningEarning decline from 2022-2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 2.54% in the last year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.51
71.29%
4.34
205.69%
3.94
171.55%
Pharmaceuticals
5.90
74.70%
4.60
133.75%
3.71
> 1,000%
COMPANY DESCRIPTION
Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical materials, functional food, pure drinking water and medical beverages in Vietnam. The company is also involved in the import and export of medicines, medicine materials, food-functional food, medical supplies, and medical equipment. It provides herbal, food, dietary supplement, and anti-epidermic products, as well as synthetic drug products such as, cardiovascular agents; antidiabetics; antibiotics; analgesics and antipyretic drugs; respiratory agents; gastrointestinal drugs; minerals and vitamins; and other synthetic drug products. The company offers its products under the Domesco brand name. The company was founded in 1989 and is headquartered in Cao Lãnh, Vietnam. Domesco Medical Import - Export Joint-Stock Corporation is a subsidiary of Abbott Laboratories(Chile) Holdco SpA.